You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IIIA non-small cell lung cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 22, 2022

Pathological Response After Neoadjuvant Treatment on NSCLC

Recruiting
  • Stage IIIA Non-small Cell Lung Cancer
  • Badalona, Barcelona, Spain
  • +16 more
Jun 1, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +10 more
  • Atezolizumab and Recombinant Human Hyaluronidase
  • Survey Administration
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +12 more
  • Computed Tomography
  • Contrast Agent
  • New Brunswick, New Jersey
  • +1 more
Nov 2, 2022

NSCLC Trial in Philadelphia (Sotorasib, 960 mg, oral daily dose for 4 weeks (28 days))

Recruiting
  • Non-Small Cell Lung Cancer
  • Sotorasib, 960 mg, oral daily dose for 4 weeks (28 days)
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 29, 2022

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

Active, not recruiting
  • Advanced Colorectal Carcinoma
  • +24 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer Trial in Los Angeles (radiation, other, drug)

Active, not recruiting
  • Adenocarcinoma of the Lung
  • +8 more
  • hypofractionated radiation therapy
  • +5 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Dec 2, 2021

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)

Recruiting
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Sacramento (Afatinib Dimaleate,

Completed
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Afatinib Dimaleate
  • Pembrolizumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Sep 29, 2021

Metastatic Malignant Tumor in the Brain, Recurrent Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial

Completed
Has Results
  • Metastatic Malignant Neoplasm in the Brain
  • +6 more
  • Bronx, New York
  • +1 more
Jan 20, 2022

Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,

Recruiting
  • Esophageal Carcinoma
  • +16 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Biopsy
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 2, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

NSCLC Stage II, NSCLC, Stage IIIA Trial in Goyang-si (Erlotinib)

Active, not recruiting
  • NSCLC Stage II
  • NSCLC, Stage IIIA
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

NSCLC Trial in Xi'an (Furmonertinib+cisplating/pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer
  • Xi'an, Shannxi, China
    Tangdu Hospital
Jun 20, 2022

NSCLC Trial in Shijiazhuang (Ensartinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shijiazhuang, Hebei, China
    Jun Feng Liu
Feb 6, 2022

NSCLC, NSCLC, Lung Cancer Trial in United States (Durvalumab, Stereotactic Body Radiation Therapy)

Recruiting
  • NSCLC
  • +7 more
  • Hartford, Connecticut
  • +8 more
Jul 7, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

Recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

NSCLC Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Chicago, Illinois
  • +11 more
Aug 31, 2022

Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston

Terminated
Has Results
  • Resectable Lung Non-Small Cell Carcinoma
  • +10 more
  • Bintrafusp Alfa
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jul 27, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
Has Results
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage II NSCLC Trial in United States (TG4010, Nivolumab)

Completed
  • Recurrent Non-Small Cell Lung Carcinoma
  • +5 more
  • TG4010
  • Nivolumab
  • Duarte, California
  • +3 more
Oct 11, 2021

Non Small Cell Lung Cancer, Secondary Lung Cancer Trial in Salt Lake City (Personalized Exercise Program)

Completed
  • Non Small Cell Lung Cancer
  • Secondary Lung Cancer
  • Personalized Exercise Program
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 9, 2022